LDL-Cholesterol is the King

Angiology. 2009 Jun-Jul;60(3):387-8. doi: 10.1177/0003319709334121. Epub 2009 Jun 3.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Anticholesteremic Agents / adverse effects
  • Anticholesteremic Agents / therapeutic use*
  • Antihypertensive Agents / adverse effects
  • Antihypertensive Agents / therapeutic use
  • Azetidines / adverse effects
  • Azetidines / therapeutic use
  • Cholesterol, LDL / blood*
  • Clinical Trials as Topic
  • Coronary Artery Disease / blood
  • Coronary Artery Disease / drug therapy*
  • Ezetimibe
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Hypercholesterolemia / blood
  • Hypercholesterolemia / drug therapy*
  • Quinolines / adverse effects
  • Quinolines / therapeutic use
  • Simvastatin / adverse effects
  • Simvastatin / therapeutic use
  • Treatment Outcome

Substances

  • Anticholesteremic Agents
  • Antihypertensive Agents
  • Azetidines
  • Cholesterol, LDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Quinolines
  • torcetrapib
  • Simvastatin
  • Ezetimibe